Tag: transdermal testosterone therapy

Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the profile of female sexual function, sexual activity log, and personal distress scale in postmenopausal women with hypoactive sexual desire disorder

This randomized controlled trial evaluated the effectiveness of transdermal testosterone therapy (TTP) in postmenopausal women with hypoactive sexual desire disorder (HSDD), demonstrating significant improvements in sexual desire, satisfying sexual activity (SSA), and reductions in personal distress. The study identified clinically meaningful changes, with responder rates in the testosterone group being

Read More »

Safety profile of transdermal testosterone therapy in women

This commentary, published in the American Journal of Obstetrics and Gynecology (2003), discusses the safety profile of transdermal testosterone therapy in postmenopausal women, particularly for treating hypoactive sexual desire disorder (HSDD). The authors highlight that clinical trials report improvements in sexual desire, arousal, and satisfaction with a low incidence of

Read More »